Cardiovascular safety of Janus kinase inhibitors in patients with rheumatoid arthritis: systematic review and network meta-analysis

Background: Janus kinase (JAK) inhibitors have emerged as a progressively utilized therapeutic approach for the management of rheumatoid arthritis (RA). However, the complete determination of their cardiovascular safety remains inconclusive. Hence, the primary objective of this network meta-analysis...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Qige Wei (Autor), Hui Wang (Autor), Jianglin Zhao (Autor), Zhongping Luo (Autor), Chufeng Wang (Autor), Chunmei Zhu (Autor), Na Su (Autor), Shengzhao Zhang (Autor)
Format: Knjiga
Izdano: Frontiers Media S.A., 2023-08-01T00:00:00Z.
Teme:
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

Connect to this object online.

3rd Floor Main Library

Detalji primjeraka od 3rd Floor Main Library
Signatura: A1234.567
Primjerak 1 Dostupno